688139.SS
688139.SS
CNE100003P25
QINGDAO HAIER BIOMEDICAL CO LTD
Loading chart...

Company Profile

Qingdao Haier Biomedical Co.,Ltd engages in the research and development, manufacture, marketing, and sale of low temperature storage equipment for biomedical samples in China and internationally. The company offers ULT freezers, pharmacy refrigerators, freezers, automatic storage solutions, cryogenics, active temperature controlled RKN containers, and RTMD products; and CO2 incubation, standard incubators, biological safety cabinets, clean benches and laminar, and sterilization products. It also provides floor standing, benchtop refrigerated, and benchtop centrifuges; intelligent pharmacy automation and RFID pharmacy products; blood bank refrigerators, blood component management products, blood plasma freezers, and transport coolers; and vaccine storage, cold/freezer room, medical waste disposal equipment, and other products. In addition, the company offers freezer and controlled rate freezers; microwave digestion system; UV visible spectrophotometer and total organic carbon analyzer products; and consumables. Further, it provides after-sales services; and U-biobank, U-vaccine, U-reagent, U-blood, and U-laboratory network solutions. The company serves hospitals, bio and pharmaceutical enterprises, universities and colleges, scientific research institutions, centers for disease control, primary public health institutions and blood stations. Qingdao Haier Biomedical Co.,Ltd was founded in 2005 and is based in Qingdao, China.

Related stocks

2675.HK
2675.HK • China
EDGE MEDICAL-B
33 HKD
1.64B USD
300529.SZ
300529.SZ • China
JAFRON
15.12 CNY
1.81B USD 1Y -31.8%
2697.HK
2697.HK • China
TH MEDICAL-B
183 HKD
1.2B USD
0853.HK
0853.HK • China
MICROPORT
6.08 HKD
1.48B USD 1Y -59%
301363.SZ
301363.SZ • China
Mehow
15.52 CNY
1.85B USD 1Y -10.3%
300206.SZ
300206.SZ • China
EDAN
11.68 CNY
1.01B USD 1Y -4.1%
688626.SS
688626.SS • China
XIANGYU MEDICAL CO LTD
40.49 CNY
969.39M USD 1Y -22.7%
688016.SS
688016.SS • China
SHANGHAI MICROPORT ENDOVASCULAR
84.9 CNY
1.57B USD 1Y -24.7%

Key Metrics & Overview

Detailed metrics & financial data of the company

Company Profile
5 Metrics

🛡️ Risk & Structural Analysis

Multi-Factor Risk Model & Market Data

7/7 Very High
5Y Volatility
40.5% p.a.
Max Drawdown (5Y)
-77.5%
Sharpe Ratio (5Y)
-0.54
Beta Factor
0.50
Size Class
Large Cap
Notes & Warnings
Single Stock Risk: Investing in an individual stock carries full company and insolvency risk (no fund diversification).
Exemplary balance sheet strength: Very solid ratio of equity to debt.
🔴 Low analyst coverage – higher uncertainty in growth estimates & projections
Structurally High Volatility: Above-average fluctuations persist across 5 to 10 years (40.5% p.a.).
Historical Stress Test: Maximum peak-to-trough drawdown of -77.5% in the extended horizon.
ende